Clinical efficacy and quality of life after transrectal natural orifice specimen extraction for the treatment of middle and upper rectal cancer.
Natural orifice specimen extraction (NOSE)
clinical efficacy
colorectal cancer
laparoscopy
quality of life (QoL)
Journal
Journal of gastrointestinal oncology
ISSN: 2078-6891
Titre abrégé: J Gastrointest Oncol
Pays: China
ID NLM: 101557751
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
14
5
2020
Statut:
ppublish
Résumé
Laparoscopic anterior resection with natural orifice specimen extraction (NOSE) avoids extra abdominal extraction incision during colorectal surgery. Some surgeons realized the benefits of NOSE on clinical efficacy. We compared the clinical efficacy of laparoscopic NOSE, laparoscopic non-NOSE and open surgery (OS) for short-term recovery and quality of life (QoL). A single randomized controlled trial of NOSE for middle and upper rectal cancer between April 2014 and February 2018. Preoperative and postoperative clinical variables were analyzed and compared between the groups. Preoperative and 6 months postoperative QoL was assessed with the SF-36 QoL questionnaire. A total of 378 patients were enrolled, 334 patients randomly divided into NOSE group (n=104), non-NOSE group (n=119), OS group (n=111). The NOSE group was superior to the other two groups on the QoL after surgery. The NOSE group had the lowest postoperative VAS score between three groups. The postoperative time for bowel function recovery and the length of hospital stay was statistically significantly different among the three groups, with the NOSE group having the shortest time. The incidence of postoperative complications was lower in the NOSE group (12/104, 11.5%) than in the non-NOSE group (20/119, 16.8%), the difference was statistically significant. The Kaplan-Meier (K-M) survival curve showed no statistically significant difference in the disease-free survival (DFS) rate between the three groups. Comparing NOSE to non-NOSE and OS, the NOSE had significantly better functional recovery and better QoL. The NOSE group had a significant lower surgical complication rate than the non-NOSE group.
Sections du résumé
BACKGROUND
BACKGROUND
Laparoscopic anterior resection with natural orifice specimen extraction (NOSE) avoids extra abdominal extraction incision during colorectal surgery. Some surgeons realized the benefits of NOSE on clinical efficacy. We compared the clinical efficacy of laparoscopic NOSE, laparoscopic non-NOSE and open surgery (OS) for short-term recovery and quality of life (QoL).
METHODS
METHODS
A single randomized controlled trial of NOSE for middle and upper rectal cancer between April 2014 and February 2018. Preoperative and postoperative clinical variables were analyzed and compared between the groups. Preoperative and 6 months postoperative QoL was assessed with the SF-36 QoL questionnaire.
RESULTS
RESULTS
A total of 378 patients were enrolled, 334 patients randomly divided into NOSE group (n=104), non-NOSE group (n=119), OS group (n=111). The NOSE group was superior to the other two groups on the QoL after surgery. The NOSE group had the lowest postoperative VAS score between three groups. The postoperative time for bowel function recovery and the length of hospital stay was statistically significantly different among the three groups, with the NOSE group having the shortest time. The incidence of postoperative complications was lower in the NOSE group (12/104, 11.5%) than in the non-NOSE group (20/119, 16.8%), the difference was statistically significant. The Kaplan-Meier (K-M) survival curve showed no statistically significant difference in the disease-free survival (DFS) rate between the three groups.
CONCLUSIONS
CONCLUSIONS
Comparing NOSE to non-NOSE and OS, the NOSE had significantly better functional recovery and better QoL. The NOSE group had a significant lower surgical complication rate than the non-NOSE group.
Identifiants
pubmed: 32399267
doi: 10.21037/jgo.2020.03.05
pii: jgo-11-02-260
pmc: PMC7212109
doi:
Types de publication
Journal Article
Langues
eng
Pagination
260-268Informations de copyright
2020 Journal of Gastrointestinal Oncology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jgo.2020.03.05). The authors have no conflicts of interest to declare.
Références
Surg Endosc. 2019 Nov;33(11):3616-3622
pubmed: 30643984
Surgery. 2013 Oct;154(4):690-5; discussion 695-6
pubmed: 24074407
Surg Endosc. 2016 Nov;30(11):5117-5125
pubmed: 27005290
Surg Endosc. 2011 Jun;25(6):2034-8
pubmed: 21136110
World J Gastroenterol. 2014 Nov 28;20(44):16707-13
pubmed: 25469041
Dis Colon Rectum. 2008 Jul;51(7):1120-4
pubmed: 18481149
J Am Coll Surg. 2016 May;222(5):814-22
pubmed: 27016903
Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1132-1142
pubmed: 30553942
Surg Endosc. 2019 Jan;33(1):79-87
pubmed: 29967994
Ann Oncol. 1998 May;9(5):549-57
pubmed: 9653497
World J Gastroenterol. 2014 Apr 7;20(13):3680-92
pubmed: 24707154
Ann Surg. 2009 Apr;249(4):596-601
pubmed: 19300230
Ann Surg. 2008 Jul;248(1):1-7
pubmed: 18580199
J Allergy Clin Immunol. 2009 Jun;123(6):1349-54
pubmed: 19368963
Colorectal Dis. 2013 Mar;15(3):347-53
pubmed: 23030665
N Engl J Med. 2004 May 13;350(20):2050-9
pubmed: 15141043
Int J Colorectal Dis. 2015 Nov;30(11):1479-88
pubmed: 26238472
Colorectal Dis. 2012 Oct;14(10):1183-8
pubmed: 22022977
World J Surg. 1993 Jan-Feb;17(1):51-6
pubmed: 8447141
Colorectal Dis. 2015 May;17(5):O123-5
pubmed: 25706915
Surg Endosc. 2009 Nov;23(11):2605-9
pubmed: 19266229
Int J Colorectal Dis. 2014 Sep;29(9):1119-24
pubmed: 24986143
Eur J Surg Oncol. 2018 Jul;44(7):1025-1030
pubmed: 29656799
Surg Endosc. 2011 Oct;25(10):3459-63
pubmed: 21553173
Surg Endosc. 2018 Mar;32(3):1336-1343
pubmed: 28842761
World J Surg. 2009 Jun;33(6):1287-91
pubmed: 19347393
Ann Surg Treat Res. 2015 Oct;89(4):190-201
pubmed: 26448918
CA Cancer J Clin. 1997 Jul-Aug;47(4):198-206
pubmed: 9242168
Int J Surg. 2016 Dec;36(Pt A):121-126
pubmed: 27780772
Tech Coloproctol. 2013 Jun;17(3):283-91
pubmed: 23179891